---
title: "OpSens and Haemonetics enter into acquisition agreement"
date: "2023-10-12T08:55:55.000Z"
publishedDate: "12 octobre 2023"
summary: "OpSens has entered into a definitive arrangement agreement with Haemonetics Corporation that will see Haemonetics indirectly acquire all of the issued and outstanding common shares in the capital of OpSens. OpSens’ board of directors unanimously approved the transaction and has recommended that shareholders vote in favour of the deal."
importance: ""
sourceUrl: "https://cardiovascularnews.com/opsens-and-haemonetics-enter-into-acquisition-agreement/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-10-12-opsens-and-haemonetics-enter-into-acquisition-agreement"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/09/opsens.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/opsens-and-haemonetics-enter-into-acquisition-agreement/"
---

![OpSens and Haemonetics enter into acquisition agreement](https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/09/opsens.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/opsens-and-haemonetics-enter-into-acquisition-agreement/*

## L’essentiel

OpSens has entered into a definitive arrangement agreement with Haemonetics Corporation that will see Haemonetics indirectly acquire all of the issued and outstanding common shares in the capital of OpSens. OpSens’ board of directors unanimously approved the transaction and has recommended that shareholders vote in favour of the deal.

## Lien source

https://cardiovascularnews.com/opsens-and-haemonetics-enter-into-acquisition-agreement/
